Center for Applied Immunology and Pathological Processes
应用免疫学和病理过程中心
基本信息
- 批准号:10360457
- 负责人:
- 金额:$ 216.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-03-01 至 2026-02-28
- 项目状态:未结题
- 来源:
- 关键词:AddressAdultAdvisory CommitteesAffectAgeAntibiotic ResistanceAntiviral resistanceAreaArthritisBacterial InfectionsBasic ScienceBone remodelingCardiovascular systemCell NucleusCell physiologyCellsCenters of Research ExcellenceCessation of lifeChlamydiaChronicClinicalCollaborationsCommunicable DiseasesCore FacilityDataDevelopmentDisciplineDiseaseEmbryonic DevelopmentEnvironmentEquipmentFacultyFosteringFoundationsFunctional disorderFundingFutureGlareGoalsGonorrheaGrantGrowthGrowth and Development functionHIVHandHealthHealth SciencesHealthcare SystemsHeart DiseasesHomeHost DefenseHumanHuman ResourcesHyperactivityImmuneImmune responseImmune systemImmunologyImmunophenotypingImmunotherapyIndividualInfectionInfection ControlInfectious AgentInflammatoryInfrastructureInternationalLeadershipLouisianaMalignant NeoplasmsMentorsMentorshipMissionModelingMolecularNeonatalPathogenesisPathologic ProcessesPathologyPlayProcessProgram DevelopmentResearchResearch InfrastructureResearch PersonnelResearch TrainingResourcesRestRoleSchoolsScienceScientific Advances and AccomplishmentsSexually Transmitted DiseasesSite-Directed MutagenesisSpecialistSyphilisTeacher Professional DevelopmentTechniquesTherapeutic InterventionTrainingTraining ProgramsUnited StatesUniversitiesViralVirus Diseasesadaptive immune responsecell growthchronic inflammatory diseasedisorder preventioneffective therapyexperiencefaculty researchhuman diseaseimmune functionimmunopathologyimprovedinsightmembermortalitynegative affectnovel therapeuticspathogenpathogenic bacteriapathogenic virusprogramsrecruitresponsestatisticssuccesssynergismtooltranslational potentialtumorwound healing
项目摘要
PROJECT SUMMARY/ABSTRACT
A properly functioning and effective immune system is needed to control infection by bacterial, viral and
other pathogen invaders, growth of aberrant cells, as well as for proper embryonic development, wound healing,
bone remodeling, and other normal homeostatic processes. Thus, understanding the innate and adaptive
immune responses and how abnormalities affect human health in chronic inflammatory conditions, during
neonatal development and how infectious diseases and cancers subvert or alter these responses is critical to
improving our health, not only in the United States, but globally. Closer to home, this unfortunately remains
especially true in the state of Louisiana, which ranks near the bottom in many national health studies. For
example, human immunodeficiency virus (HIV) age adjusted deaths in the state are more than double the
national average, while the state ranks in the top 5 in infections with the sexually transmitted diseases, Syphilis,
Gonorrhea and Chlamydia. In addition, as is documented for many states in the south, Louisiana has some of
the highest rates of arthritis (affecting ~1 in 4 adults in the state), heart disease and cardiovascular deaths
(ranked 46/50 and 48/50 respectively), and cancer-related mortality rates (15-20% higher than the national
average) in the nation. These glaring statistics support the need for additional understanding of the pathogenesis
of these diseases and new options for therapeutic interventions. One common theme among these different
diseases is an aberrant immune response and resulting immunopathologies. Thus, we propose a better
understanding of how aberrations in the immune system result in disease is needed. We propose that a targeted
growth of an immunology-centric center on our campus at LSUHSC-S will positively influence the health of our
citizens. This is especially true as new research shows targeted modifications of the immune response or
immunotherapy holds great promise as an effective treatment option to control and eradicate various tumors, for
the treatment and mitigation of antibiotic or antiviral resistant infectious diseases, and for the prevention of
chronic inflammatory diseases, etc.
Diverse research into aspects of immunology, host pathogen interactions, and the immunopathology
associated with an abnormal immune response is an important priority at LSU Health Sciences Center
Shreveport (LSUHSC-S) within multiple centers and departments. Immunology as a discipline can effectively
bridge many centers and departments currently on campus and thus serve as a nucleus for collaborative and
synergistic research across diverse disciplines. Immunology as a discipline is now at the forefront of novel
therapies to control bacterial infections, viral infections, to treat cancer; thus an expansion and growth of this
area at LSUHSC-S will advance the mission of the school to grow basic science that has strong translational
potential. The objective of this new COBRE Center for Applied Immunology and Pathological Processes
(CAIPP) to establish an independent internationally recognized research and training program at
LSUHSC-S. We propose to first mentor and develop federally funded junior faculty research and to develop
new infrastructure to support the growth and continued hiring in this important area of biomedical science.
Because Dr. Yurochko has 35 years of experience in immunology research, has been a junior PI in a COBRE
center, Project Mentor for successful projects and part of a COBRE leadership team, he can draw on a wealth
of experiences, along with those of the experienced leadership team, to drive the success of the CAIPP. Second,
we propose long term to retain these immunology researchers as they become more senior through promotion,
to become an international recognized research hub and to elevate the CAIPP within LSUHSC-S by becoming
a state recognized Center. We shall take advantage of the strengths currently on campus and through targeted
recruitment to grow the CAIPP COBRE around the focused understanding of “aberrant immune cell function and
the resulting immunopathology”. The cores address critical research needs on campus and are ultimately
essential for the long-term growth and status of research at LSUHSC-S. The cores build upon existing equipment
and infrastructure and bring new expertise not currently available on campus; thus, they fill a needed gap in
research infrastructure. Recent polling of the faculty document that all centers and most faculty (>80%) on
campus will utilize/require both proposed cores to generate the needed new data for competitive national grant
submissions. In summary, the major goals of this CAIPP COBRE application are to: establish a strong and
consistent mentorship and professional development program that meet the individual needs of each investigator
(and thus are tailored for the needs of that investigator); establish advanced research core facilities that support
the university, the region and the state; advance the mechanistic and clinical understanding for how subversion
of the immune response and functioning of immune cells influences human health and disease; and lastly to
create an academically and financially independent and internationally recognized Center of Excellence. We
support these major goals through our initial collaboration within centers and departments within the school and
the entire northern region of the state and to then grow this collaboration through engagement and collaborations
with colleagues in the rest of the state once we have established the foundation of the proposed CAIPP.
项目概要/摘要
需要功能正常且有效的免疫系统来控制细菌、病毒和
其他病原体入侵,异常细胞的生长,以及适当的胚胎发育,伤口愈合,
骨重塑和其他正常的稳态过程,从而了解先天性和适应性。
免疫反应以及异常如何影响慢性炎症条件下的人类健康,
新生儿发育以及传染病和癌症如何颠覆或改变这些反应对于
不幸的是,这不仅在美国,而且在全球范围内,都在改善我们的健康。
在路易斯安那州尤其如此,该州在许多国家健康研究中排名接近垫底。
例如,该州的人类免疫缺陷病毒 (HIV) 年龄调整死亡人数是美国的两倍多
全国平均水平,而该州的性传播疾病、梅毒、
此外,根据南部许多州的记录,路易斯安那州也有一些淋病和衣原体感染。
关节炎(影响该州约四分之一的成年人)、心脏病和心血管疾病死亡率最高
(分别排名 46/50 和 48/50)和癌症相关死亡率(比全国高 15-20%)
这些明显的统计数据支持对发病机制有更多了解的必要性。
这些不同疾病的共同主题以及治疗干预的新选择。
疾病是一种异常的免疫反应和由此产生的免疫病理学,因此,我们提出了更好的方法。
我们需要了解免疫系统的异常如何导致疾病。
LSUHSC-S 校园内以免疫学为中心的中心的发展将对我们学生的健康产生积极影响
尤其是当新的研究表明免疫反应或免疫反应有针对性的改变时。
免疫疗法作为控制和根除各种肿瘤的有效治疗选择具有广阔的前景
治疗和缓解抗生素或抗病毒药物耐药性传染病,以及预防
慢性炎症性疾病等。
免疫学、宿主病原体相互作用和免疫病理学方面的多样化研究
与异常免疫反应相关是路易斯安那州立大学健康科学中心的一个重要优先事项
什里夫波特(LSUHSC-S)多个中心和部门的免疫学作为一门学科可以有效地发挥作用。
连接目前校园内的许多中心和部门,从而成为协作和合作的核心
跨学科的协同研究免疫学作为一门学科现在处于新颖的前沿。
控制细菌感染、病毒感染、治疗癌症的疗法;
LSUHSC-S 领域将推进学校发展具有强大转化能力的基础科学的使命
新的 COBRE 应用免疫学和病理过程中心的目标。
(CAIPP) 在以下地点建立一个独立的国际认可的研究和培训项目
我们建议首先指导和发展联邦政府资助的初级教师研究并发展
新的基础设施支持生物医学这一重要领域的增长和持续招聘。
因为Yurochko博士拥有35年的免疫学研究经验,曾在COBRE担任初级PI
中心、成功项目的项目导师以及 COBRE 领导团队的一部分,他可以利用财富
丰富的经验以及经验丰富的领导团队的经验,推动 CAIPP 的成功。
我们建议长期留住这些免疫学研究人员,因为他们通过晋升变得更加资深,
成为国际公认的研究中心,并通过成为 LSUHSC-S 内的 CAIPP 来提升
我们将利用校园现有的优势并通过有针对性的方式。
CAIPP COBRE 的招募围绕着对“异常免疫细胞功能和
由此产生的免疫病理学”,核心解决了校园的关键研究需求,并最终得到解决。
对于 LSUHSC-S 的长期发展和研究地位至关重要 这些核心建立在现有设备的基础上。
和基础设施,并带来校园目前没有的新专业知识;因此,他们填补了所需的空白;
最近对教职员工的民意调查显示,所有中心和大多数教职员工(>80%)都支持研究基础设施。
校园将利用/需要两个拟议的核心来生成竞争性国家拨款所需的新数据
总之,该 CAIPP COBRE 应用程序的主要目标是: 建立一个强大且可靠的平台。
一致的指导和专业发展计划,满足每位研究者的个人需求
(从而根据该研究者的需求进行定制);建立支持的先进研究核心设施;
大学、地区和国家;促进对如何颠覆的机制和临床理解;
免疫反应和免疫细胞功能影响人类健康和疾病;
创建一个学术和财务独立且国际认可的卓越中心。
通过我们在学校内的中心和部门之间的初步合作来支持这些主要目标,
该州的整个北部地区,然后通过参与和合作来扩大这种合作
一旦我们为拟议的 CAIPP 奠定了基础,我们就会与该州其他地区的同事合作。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANDREW D YUROCHKO其他文献
ANDREW D YUROCHKO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANDREW D YUROCHKO', 18)}}的其他基金
Center for Applied Immunology and Pathological Processes
应用免疫学和病理过程中心
- 批准号:
10569050 - 财政年份:2021
- 资助金额:
$ 216.01万 - 项目类别:
Center for Applied Immunology and Pathological Processes
应用免疫学和病理过程中心
- 批准号:
10090768 - 财政年份:2021
- 资助金额:
$ 216.01万 - 项目类别:
Center for Applied Immunology and Pathological Processes
应用免疫学和病理过程中心
- 批准号:
10090768 - 财政年份:2021
- 资助金额:
$ 216.01万 - 项目类别:
HCMV regulation of host cell signaling and cytokines in myelosuppression
HCMV 在骨髓抑制中对宿主细胞信号传导和细胞因子的调节
- 批准号:
9980285 - 财政年份:2017
- 资助金额:
$ 216.01万 - 项目类别:
HCMV regulation of host cell signaling and cytokines in myelosuppression
HCMV 在骨髓抑制中对宿主细胞信号传导和细胞因子的调节
- 批准号:
10216638 - 财政年份:2017
- 资助金额:
$ 216.01万 - 项目类别:
HCMV regulation of monocyte/macrophage host cell signaling in viral reactivation
HCMV 对病毒再激活中单核细胞/巨噬细胞宿主细胞信号传导的调节
- 批准号:
10629186 - 财政年份:2017
- 资助金额:
$ 216.01万 - 项目类别:
相似国自然基金
基于动态信息的深度学习辅助设计成人脊柱畸形手术方案的研究
- 批准号:82372499
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
单核细胞产生S100A8/A9放大中性粒细胞炎症反应调控成人Still病发病及病情演变的机制研究
- 批准号:82373465
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SERPINF1/SRSF6/B7-H3信号通路在成人B-ALL免疫逃逸中的作用及机制研究
- 批准号:82300208
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Characterizing the genetic etiology of delayed puberty with integrative genomic techniques
利用综合基因组技术表征青春期延迟的遗传病因
- 批准号:
10663605 - 财政年份:2023
- 资助金额:
$ 216.01万 - 项目类别:
Implementing SafeCare Kenya to Reduce Noncommunicable Disease Burden: Building Community Health Workers' Capacity to Support Parents with Young Children
实施 SafeCare Kenya 以减少非传染性疾病负担:建设社区卫生工作者支持有幼儿的父母的能力
- 批准号:
10672785 - 财政年份:2023
- 资助金额:
$ 216.01万 - 项目类别:
A cloud-based digital health navigation program for colorectal cancer screening
基于云的结直肠癌筛查数字健康导航程序
- 批准号:
10697474 - 财政年份:2023
- 资助金额:
$ 216.01万 - 项目类别:
Center for Harmonizing and Improving Interventions to Prevent Suicide (CHIIPS)
协调和改进预防自杀干预措施中心 (CHIIPS)
- 批准号:
10662785 - 财政年份:2023
- 资助金额:
$ 216.01万 - 项目类别:
Sex, Physiological State, and Genetic Background Dependent Molecular Characterization of CircuitsGoverning Parental Behavior
控制父母行为的回路的性别、生理状态和遗传背景依赖性分子特征
- 批准号:
10661884 - 财政年份:2023
- 资助金额:
$ 216.01万 - 项目类别: